Conditions: Papulopustular Rosacea (PPR)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 683
Healthy volunteers: no

Brief summary:
The purpose of this study is to demonstrate that CD5024 1% cream is more effective than its vehicle when applied once daily, at bed time, during a 12 week period in subjects with Papulopustular Rosacea (PPR) and continues to be safe up to 12 months.

Detailed description:

Arms:
arm 1: CD5024 1% Cream arm 2: CD5024 Vehicle Cream

Interventions: intervention 1: CD5024 intervention 2: Azelaic acid 15% Gel
Intervention descriptions: intervention 1: CD5024 1% Cream, once daily intervention 2: Topical Gel applied twice daily

Protocol document: